Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Airbnb
ABNB
|
+$1.45B |
| 2 |
Snap
SNAP
|
+$1B |
| 3 |
Sea Limited
SE
|
+$981M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$839M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
AbbVie
ABBV
|
+$1.58B |
| 3 |
Mastercard
MA
|
+$1.56B |
| 4 |
Alibaba
BABA
|
+$1.37B |
| 5 |
Union Pacific
UNP
|
+$1.22B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.97% |
| 2 | Healthcare | 13.85% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Communication Services | 12.15% |
| 5 | Financials | 12.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
SPX Corp
SPXC
$10.8B
| $57.1M | ﹤0.01% |
1,068,820
-268,534
| -20% | -$16.5M |
|
1352
Cytek Biosciences
CTKB
$546M
| $57.1M | ﹤0.01% |
+2,666,600
| New | +$62.7M |
|
1353
Magna International
MGA
$18.8B
| $57.1M | ﹤0.01% |
758,314
-20,077
| -3% | -$1.65M |
|
1354
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $56.9M | ﹤0.01% |
1,602,664
-15,260
| -0.9% | -$514K |
|
1355
Cullinan Oncology
CGEM
$1.14B
| $56.4M | ﹤0.01% |
2,500,212
+522,305
| +26% | +$14M |
|
|
EVLO
1356
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $56.4M | ﹤0.01% |
400,487
+183
| +0% | +$36.3K |
|
1357
Planet Fitness
PLNT
$3.78B
| $56.2M | ﹤0.01% |
714,983
-1,226,013
| -63% | -$93.2M |
|
1358
Passage Bio
PASG
$14.1M
| $56.1M | ﹤0.01% |
281,628
-46,537
| -14% | -$11.1M |
|
1359
Dole
DOLE
$1.32B
| $55.8M | ﹤0.01% |
+3,291,573
| New | +$50.7M |
|
|
AKUS
1360
DELISTED
Akouos Inc
AKUS
| $55.6M | ﹤0.01% |
4,793,028
+117,326
| +3% | +$1.41M |
|
1361
BHP
BHP
$230B
| $55.6M | ﹤0.01% |
1,165,489
-4,821,205
| -81% | -$294M |
|
1362
iShares Core Universal USD Bond ETF
IUSB
$43.3B
| $55.6M | ﹤0.01% |
1,044,888
-72,262
| -6% | -$3.88M |
|
1363
Hanmi Financial
HAFC
$946M
| $55.4M | ﹤0.01% |
2,759,619
+3,910
| +0.1% | +$72.4K |
|
1364
Hamilton Lane
HLNE
$5.57B
| $55.3M | ﹤0.01% |
652,484
-22,735
| -3% | -$2.04M |
|
1365
Delek US
DK
$3.58B
| $55.2M | ﹤0.01% |
3,074,105
-129
| -0% | -$2.2K |
|
1366
Outfront Media
OUT
$5.5B
| $55.1M | ﹤0.01% |
2,223,160
-630,628
| -22% | -$14.9M |
|
|
UMH
1367
UMH Properties
UMH
$1.36B
| $54.9M | ﹤0.01% |
2,396,091
-9
| -0% | -$210 |
|
1368
Medpace
MEDP
$16.5B
| $54.7M | ﹤0.01% |
288,998
+14,457
| +5% | +$2.64M |
|
|
CDAK
1369
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $54.7M | ﹤0.01% |
3,349,683
+43,101
| +1% | +$771K |
|
1370
FNB Corp
FNB
$6.75B
| $54.3M | ﹤0.01% |
4,670,578
-11,886
| -0.3% | -$137K |
|
1371
ESCO Technologies
ESE
$7.92B
| $54.2M | ﹤0.01% |
703,638
+59,335
| +9% | +$5.25M |
|
1372
Warrior Met Coal
HCC
$4.86B
| $53.6M | ﹤0.01% |
2,303,121
| – | – |
|
|
CMBT
1373
CMB.TECH NV
CMBT
$4.73B
| $53.6M | ﹤0.01% |
5,572,166
+759,105
| +16% | +$6.48M |
|
1374
Popular Inc
BPOP
$11.1B
| $53.4M | ﹤0.01% |
687,911
+70,311
| +11% | +$5.23M |
|
|
APLS
1375
DELISTED
Apellis Pharmaceuticals
APLS
| $53.2M | ﹤0.01% |
1,614,859
+143,694
| +10% | +$8.07M |
|
Similar funds
Fidelity Investments's Q3 2021 Portfolio in Review
As of Q3 2021, Fidelity Investments held 5,415 positions worth $1.26T, down 1.2% from $1.28T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fidelity Investments's Q3 2021 filing shows 435 new, 1,865 increased, 1,814 reduced and 523 closed positions. Its largest new stake was Invivyd: 16,687,749 shares worth $663M. The largest sale was NVIDIA, an estimated $1.81B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q3 2021 buy was Invivyd: 16,687,749 shares worth $663M.
- Fidelity Investments added most to Airbnb in Q3 2021, an estimated $1.45B increase.
- Fidelity Investments's biggest Q3 2021 reduction was NVIDIA, cutting an estimated $1.81B.
- Fidelity Investments fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $740M.
- Fidelity Investments's ten largest holdings make up 28% of its $1.26T portfolio in Q3 2021.
- Fidelity Investments opened 435 new positions and closed 523 in Q3 2021.
- Fidelity Investments's portfolio value fell 1.2% quarter-over-quarter to $1.26T.
Based on Fidelity Investments's 13F filing for Q3 2021, filed 15 Nov 2021.